GO:0005654 | nucleoplasm | 1.49e-08 | 2.43e-04 | 3.367 | 9 | 83 | 1095 |
GO:0000278 | mitotic cell cycle | 3.01e-07 | 4.91e-03 | 4.242 | 6 | 52 | 398 |
GO:0005829 | cytosol | 1.62e-06 | 2.64e-02 | 2.293 | 10 | 125 | 2562 |
GO:0070062 | extracellular vesicular exosome | 1.92e-05 | 3.13e-01 | 2.167 | 9 | 98 | 2516 |
GO:0016071 | mRNA metabolic process | 2.20e-05 | 3.59e-01 | 4.493 | 4 | 34 | 223 |
GO:0016070 | RNA metabolic process | 3.29e-05 | 5.37e-01 | 4.346 | 4 | 34 | 247 |
GO:0035267 | NuA4 histone acetyltransferase complex | 5.30e-05 | 8.65e-01 | 7.487 | 2 | 4 | 14 |
GO:0043234 | protein complex | 7.02e-05 | 1.00e+00 | 4.065 | 4 | 17 | 300 |
GO:0010467 | gene expression | 1.12e-04 | 1.00e+00 | 3.230 | 5 | 58 | 669 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.47e-04 | 1.00e+00 | 6.770 | 2 | 4 | 23 |
GO:0006206 | pyrimidine nucleobase metabolic process | 1.60e-04 | 1.00e+00 | 6.709 | 2 | 2 | 24 |
GO:0031492 | nucleosomal DNA binding | 2.19e-04 | 1.00e+00 | 6.487 | 2 | 4 | 28 |
GO:0005634 | nucleus | 5.72e-04 | 1.00e+00 | 1.379 | 10 | 131 | 4828 |
GO:0005515 | protein binding | 6.98e-04 | 1.00e+00 | 1.172 | 11 | 172 | 6127 |
GO:0006521 | regulation of cellular amino acid metabolic process | 7.02e-04 | 1.00e+00 | 5.650 | 2 | 21 | 50 |
GO:0031100 | organ regeneration | 7.02e-04 | 1.00e+00 | 5.650 | 2 | 4 | 50 |
GO:0004151 | dihydroorotase activity | 7.97e-04 | 1.00e+00 | 10.294 | 1 | 1 | 1 |
GO:0019521 | D-gluconate metabolic process | 7.97e-04 | 1.00e+00 | 10.294 | 1 | 1 | 1 |
GO:0004070 | aspartate carbamoyltransferase activity | 7.97e-04 | 1.00e+00 | 10.294 | 1 | 1 | 1 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 7.97e-04 | 1.00e+00 | 10.294 | 1 | 1 | 1 |
GO:0070335 | aspartate binding | 7.97e-04 | 1.00e+00 | 10.294 | 1 | 1 | 1 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 8.19e-04 | 1.00e+00 | 5.539 | 2 | 5 | 54 |
GO:0000502 | proteasome complex | 9.44e-04 | 1.00e+00 | 5.436 | 2 | 22 | 58 |
GO:0042995 | cell projection | 1.11e-03 | 1.00e+00 | 5.317 | 2 | 6 | 63 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.18e-03 | 1.00e+00 | 5.272 | 2 | 24 | 65 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 1.18e-03 | 1.00e+00 | 5.272 | 2 | 22 | 65 |
GO:0016020 | membrane | 1.31e-03 | 1.00e+00 | 2.109 | 6 | 80 | 1746 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.37e-03 | 1.00e+00 | 5.165 | 2 | 24 | 70 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 1.49e-03 | 1.00e+00 | 5.104 | 2 | 23 | 73 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 1.49e-03 | 1.00e+00 | 5.104 | 2 | 5 | 73 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.53e-03 | 1.00e+00 | 5.085 | 2 | 24 | 74 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.59e-03 | 1.00e+00 | 9.294 | 1 | 1 | 2 |
GO:0019322 | pentose biosynthetic process | 1.59e-03 | 1.00e+00 | 9.294 | 1 | 1 | 2 |
GO:0005055 | laminin receptor activity | 1.59e-03 | 1.00e+00 | 9.294 | 1 | 1 | 2 |
GO:0006407 | rRNA export from nucleus | 1.59e-03 | 1.00e+00 | 9.294 | 1 | 1 | 2 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 1.59e-03 | 1.00e+00 | 9.294 | 1 | 1 | 2 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.66e-03 | 1.00e+00 | 5.027 | 2 | 23 | 77 |
GO:0006334 | nucleosome assembly | 1.74e-03 | 1.00e+00 | 4.990 | 2 | 4 | 79 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.74e-03 | 1.00e+00 | 4.990 | 2 | 25 | 79 |
GO:0044281 | small molecule metabolic process | 2.34e-03 | 1.00e+00 | 2.277 | 5 | 57 | 1295 |
GO:0016363 | nuclear matrix | 2.35e-03 | 1.00e+00 | 4.770 | 2 | 11 | 92 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 2.39e-03 | 1.00e+00 | 8.709 | 1 | 1 | 3 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 2.39e-03 | 1.00e+00 | 8.709 | 1 | 1 | 3 |
GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor | 2.39e-03 | 1.00e+00 | 8.709 | 1 | 1 | 3 |
GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 2.39e-03 | 1.00e+00 | 8.709 | 1 | 1 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 2.39e-03 | 1.00e+00 | 8.709 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 2.39e-03 | 1.00e+00 | 8.709 | 1 | 1 | 3 |
GO:0005200 | structural constituent of cytoskeleton | 2.41e-03 | 1.00e+00 | 4.755 | 2 | 7 | 93 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 2.46e-03 | 1.00e+00 | 4.739 | 2 | 23 | 94 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 3.18e-03 | 1.00e+00 | 8.294 | 1 | 1 | 4 |
GO:0000212 | meiotic spindle organization | 3.18e-03 | 1.00e+00 | 8.294 | 1 | 1 | 4 |
GO:0030686 | 90S preribosome | 3.18e-03 | 1.00e+00 | 8.294 | 1 | 1 | 4 |
GO:0006543 | glutamine catabolic process | 3.18e-03 | 1.00e+00 | 8.294 | 1 | 1 | 4 |
GO:0030529 | ribonucleoprotein complex | 3.59e-03 | 1.00e+00 | 4.461 | 2 | 8 | 114 |
GO:0000209 | protein polyubiquitination | 3.71e-03 | 1.00e+00 | 4.436 | 2 | 21 | 116 |
GO:0051414 | response to cortisol | 3.98e-03 | 1.00e+00 | 7.972 | 1 | 1 | 5 |
GO:0043248 | proteasome assembly | 3.98e-03 | 1.00e+00 | 7.972 | 1 | 1 | 5 |
GO:0001940 | male pronucleus | 3.98e-03 | 1.00e+00 | 7.972 | 1 | 1 | 5 |
GO:0005827 | polar microtubule | 3.98e-03 | 1.00e+00 | 7.972 | 1 | 1 | 5 |
GO:0006325 | chromatin organization | 4.16e-03 | 1.00e+00 | 4.351 | 2 | 4 | 123 |
GO:0006260 | DNA replication | 4.30e-03 | 1.00e+00 | 4.328 | 2 | 12 | 125 |
GO:0030957 | Tat protein binding | 4.77e-03 | 1.00e+00 | 7.709 | 1 | 4 | 6 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 4.77e-03 | 1.00e+00 | 7.709 | 1 | 1 | 6 |
GO:0000790 | nuclear chromatin | 4.85e-03 | 1.00e+00 | 4.239 | 2 | 7 | 133 |
GO:0000086 | G2/M transition of mitotic cell cycle | 5.14e-03 | 1.00e+00 | 4.196 | 2 | 7 | 137 |
GO:0000028 | ribosomal small subunit assembly | 5.56e-03 | 1.00e+00 | 7.487 | 1 | 1 | 7 |
GO:0000930 | gamma-tubulin complex | 5.56e-03 | 1.00e+00 | 7.487 | 1 | 1 | 7 |
GO:0001939 | female pronucleus | 5.56e-03 | 1.00e+00 | 7.487 | 1 | 1 | 7 |
GO:0000082 | G1/S transition of mitotic cell cycle | 6.12e-03 | 1.00e+00 | 4.065 | 2 | 33 | 150 |
GO:0042981 | regulation of apoptotic process | 6.20e-03 | 1.00e+00 | 4.056 | 2 | 26 | 151 |
GO:0044267 | cellular protein metabolic process | 6.32e-03 | 1.00e+00 | 2.928 | 3 | 24 | 495 |
GO:0019773 | proteasome core complex, alpha-subunit complex | 6.36e-03 | 1.00e+00 | 7.294 | 1 | 5 | 8 |
GO:0035067 | negative regulation of histone acetylation | 6.36e-03 | 1.00e+00 | 7.294 | 1 | 1 | 8 |
GO:0070688 | MLL5-L complex | 6.36e-03 | 1.00e+00 | 7.294 | 1 | 1 | 8 |
GO:0000812 | Swr1 complex | 6.36e-03 | 1.00e+00 | 7.294 | 1 | 3 | 8 |
GO:0006228 | UTP biosynthetic process | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 9 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 9 |
GO:0014075 | response to amine | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 9 |
GO:0031000 | response to caffeine | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 2 | 9 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 7.63e-03 | 1.00e+00 | 3.902 | 2 | 5 | 168 |
GO:0016032 | viral process | 8.04e-03 | 1.00e+00 | 2.802 | 3 | 55 | 540 |
GO:0034641 | cellular nitrogen compound metabolic process | 8.43e-03 | 1.00e+00 | 3.826 | 2 | 25 | 177 |
GO:0006098 | pentose-phosphate shunt | 8.73e-03 | 1.00e+00 | 6.835 | 1 | 3 | 11 |
GO:0019789 | SUMO ligase activity | 8.73e-03 | 1.00e+00 | 6.835 | 1 | 1 | 11 |
GO:0021846 | cell proliferation in forebrain | 8.73e-03 | 1.00e+00 | 6.835 | 1 | 1 | 11 |
GO:0033762 | response to glucagon | 8.73e-03 | 1.00e+00 | 6.835 | 1 | 1 | 11 |
GO:0051290 | protein heterotetramerization | 8.73e-03 | 1.00e+00 | 6.835 | 1 | 2 | 11 |
GO:0045120 | pronucleus | 8.73e-03 | 1.00e+00 | 6.835 | 1 | 1 | 11 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 9.52e-03 | 1.00e+00 | 6.709 | 1 | 2 | 12 |
GO:0043968 | histone H2A acetylation | 9.52e-03 | 1.00e+00 | 6.709 | 1 | 3 | 12 |
GO:0005838 | proteasome regulatory particle | 9.52e-03 | 1.00e+00 | 6.709 | 1 | 7 | 12 |
GO:0008266 | poly(U) RNA binding | 1.03e-02 | 1.00e+00 | 6.594 | 1 | 1 | 13 |
GO:0007020 | microtubule nucleation | 1.11e-02 | 1.00e+00 | 6.487 | 1 | 1 | 14 |
GO:0007095 | mitotic G2 DNA damage checkpoint | 1.11e-02 | 1.00e+00 | 6.487 | 1 | 1 | 14 |
GO:0031011 | Ino80 complex | 1.11e-02 | 1.00e+00 | 6.487 | 1 | 3 | 14 |
GO:0050998 | nitric-oxide synthase binding | 1.27e-02 | 1.00e+00 | 6.294 | 1 | 1 | 16 |
GO:0006337 | nucleosome disassembly | 1.35e-02 | 1.00e+00 | 6.207 | 1 | 4 | 17 |
GO:0022624 | proteasome accessory complex | 1.35e-02 | 1.00e+00 | 6.207 | 1 | 9 | 17 |
GO:0007067 | mitotic nuclear division | 1.40e-02 | 1.00e+00 | 3.442 | 2 | 13 | 231 |
GO:0006541 | glutamine metabolic process | 1.42e-02 | 1.00e+00 | 6.124 | 1 | 1 | 18 |
GO:0031122 | cytoplasmic microtubule organization | 1.42e-02 | 1.00e+00 | 6.124 | 1 | 2 | 18 |
GO:0015949 | nucleobase-containing small molecule interconversion | 1.42e-02 | 1.00e+00 | 6.124 | 1 | 2 | 18 |
GO:0005839 | proteasome core complex | 1.42e-02 | 1.00e+00 | 6.124 | 1 | 11 | 18 |
GO:0003678 | DNA helicase activity | 1.50e-02 | 1.00e+00 | 6.046 | 1 | 3 | 19 |
GO:0048863 | stem cell differentiation | 1.50e-02 | 1.00e+00 | 6.046 | 1 | 1 | 19 |
GO:0008601 | protein phosphatase type 2A regulator activity | 1.58e-02 | 1.00e+00 | 5.972 | 1 | 3 | 20 |
GO:0004298 | threonine-type endopeptidase activity | 1.58e-02 | 1.00e+00 | 5.972 | 1 | 11 | 20 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 1.66e-02 | 1.00e+00 | 5.902 | 1 | 1 | 21 |
GO:0043025 | neuronal cell body | 1.68e-02 | 1.00e+00 | 3.305 | 2 | 4 | 254 |
GO:0033574 | response to testosterone | 1.74e-02 | 1.00e+00 | 5.835 | 1 | 2 | 22 |
GO:0030863 | cortical cytoskeleton | 1.74e-02 | 1.00e+00 | 5.835 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.74e-02 | 1.00e+00 | 5.835 | 1 | 4 | 22 |
GO:0043236 | laminin binding | 1.82e-02 | 1.00e+00 | 5.770 | 1 | 1 | 23 |
GO:0005524 | ATP binding | 1.84e-02 | 1.00e+00 | 1.891 | 4 | 46 | 1354 |
GO:0000794 | condensed nuclear chromosome | 1.90e-02 | 1.00e+00 | 5.709 | 1 | 2 | 24 |
GO:0004864 | protein phosphatase inhibitor activity | 1.97e-02 | 1.00e+00 | 5.650 | 1 | 1 | 25 |
GO:0017144 | drug metabolic process | 1.97e-02 | 1.00e+00 | 5.650 | 1 | 1 | 25 |
GO:0005737 | cytoplasm | 2.11e-02 | 1.00e+00 | 1.144 | 7 | 98 | 3976 |
GO:0006913 | nucleocytoplasmic transport | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 2 | 27 |
GO:0034080 | CENP-A containing nucleosome assembly | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 2 | 27 |
GO:0016925 | protein sumoylation | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 1 | 27 |
GO:0071339 | MLL1 complex | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 3 | 27 |
GO:0043022 | ribosome binding | 2.21e-02 | 1.00e+00 | 5.487 | 1 | 3 | 28 |
GO:0043967 | histone H4 acetylation | 2.21e-02 | 1.00e+00 | 5.487 | 1 | 3 | 28 |
GO:0019894 | kinesin binding | 2.21e-02 | 1.00e+00 | 5.487 | 1 | 1 | 28 |
GO:0003730 | mRNA 3'-UTR binding | 2.29e-02 | 1.00e+00 | 5.436 | 1 | 2 | 29 |
GO:0050661 | NADP binding | 2.52e-02 | 1.00e+00 | 5.294 | 1 | 1 | 32 |
GO:0019901 | protein kinase binding | 2.59e-02 | 1.00e+00 | 2.972 | 2 | 21 | 320 |
GO:0034332 | adherens junction organization | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 1 | 36 |
GO:0001895 | retina homeostasis | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 1 | 36 |
GO:0018107 | peptidyl-threonine phosphorylation | 2.91e-02 | 1.00e+00 | 5.085 | 1 | 1 | 37 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.91e-02 | 1.00e+00 | 5.085 | 1 | 4 | 37 |
GO:0070527 | platelet aggregation | 2.99e-02 | 1.00e+00 | 5.046 | 1 | 2 | 38 |
GO:0022627 | cytosolic small ribosomal subunit | 3.06e-02 | 1.00e+00 | 5.009 | 1 | 3 | 39 |
GO:0007595 | lactation | 3.06e-02 | 1.00e+00 | 5.009 | 1 | 2 | 39 |
GO:0043195 | terminal bouton | 3.22e-02 | 1.00e+00 | 4.936 | 1 | 1 | 41 |
GO:0032508 | DNA duplex unwinding | 3.30e-02 | 1.00e+00 | 4.902 | 1 | 4 | 42 |
GO:0010212 | response to ionizing radiation | 3.37e-02 | 1.00e+00 | 4.868 | 1 | 1 | 43 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 3.45e-02 | 1.00e+00 | 4.835 | 1 | 3 | 44 |
GO:0048146 | positive regulation of fibroblast proliferation | 3.45e-02 | 1.00e+00 | 4.835 | 1 | 2 | 44 |
GO:0021762 | substantia nigra development | 3.60e-02 | 1.00e+00 | 4.770 | 1 | 1 | 46 |
GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity | 3.68e-02 | 1.00e+00 | 4.739 | 1 | 3 | 47 |
GO:0035690 | cellular response to drug | 3.91e-02 | 1.00e+00 | 4.650 | 1 | 2 | 50 |
GO:0040008 | regulation of growth | 3.99e-02 | 1.00e+00 | 4.622 | 1 | 3 | 51 |
GO:0060041 | retina development in camera-type eye | 4.14e-02 | 1.00e+00 | 4.566 | 1 | 3 | 53 |
GO:0000226 | microtubule cytoskeleton organization | 4.29e-02 | 1.00e+00 | 4.513 | 1 | 3 | 55 |
GO:0000932 | cytoplasmic mRNA processing body | 4.37e-02 | 1.00e+00 | 4.487 | 1 | 3 | 56 |
GO:0043066 | negative regulation of apoptotic process | 4.52e-02 | 1.00e+00 | 2.536 | 2 | 30 | 433 |
GO:0045216 | cell-cell junction organization | 4.60e-02 | 1.00e+00 | 4.411 | 1 | 2 | 59 |
GO:0044822 | poly(A) RNA binding | 4.99e-02 | 1.00e+00 | 1.805 | 3 | 50 | 1078 |
GO:0006310 | DNA recombination | 5.21e-02 | 1.00e+00 | 4.228 | 1 | 4 | 67 |
GO:0050790 | regulation of catalytic activity | 5.36e-02 | 1.00e+00 | 4.185 | 1 | 3 | 69 |
GO:0055114 | oxidation-reduction process | 5.45e-02 | 1.00e+00 | 2.384 | 2 | 11 | 481 |
GO:0042393 | histone binding | 5.51e-02 | 1.00e+00 | 4.144 | 1 | 3 | 71 |
GO:0034329 | cell junction assembly | 5.51e-02 | 1.00e+00 | 4.144 | 1 | 1 | 71 |
GO:0042802 | identical protein binding | 5.66e-02 | 1.00e+00 | 2.354 | 2 | 18 | 491 |
GO:0032355 | response to estradiol | 5.66e-02 | 1.00e+00 | 4.104 | 1 | 5 | 73 |
GO:0043086 | negative regulation of catalytic activity | 5.74e-02 | 1.00e+00 | 4.085 | 1 | 2 | 74 |
GO:0007265 | Ras protein signal transduction | 5.81e-02 | 1.00e+00 | 4.065 | 1 | 3 | 75 |
GO:0008584 | male gonad development | 5.96e-02 | 1.00e+00 | 4.027 | 1 | 2 | 77 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 5.96e-02 | 1.00e+00 | 4.027 | 1 | 5 | 77 |
GO:0071013 | catalytic step 2 spliceosome | 6.12e-02 | 1.00e+00 | 3.990 | 1 | 7 | 79 |
GO:0007565 | female pregnancy | 6.19e-02 | 1.00e+00 | 3.972 | 1 | 2 | 80 |
GO:0019083 | viral transcription | 6.27e-02 | 1.00e+00 | 3.954 | 1 | 8 | 81 |
GO:0001889 | liver development | 6.34e-02 | 1.00e+00 | 3.936 | 1 | 3 | 82 |
GO:0005681 | spliceosomal complex | 6.42e-02 | 1.00e+00 | 3.919 | 1 | 3 | 83 |
GO:0006415 | translational termination | 6.71e-02 | 1.00e+00 | 3.851 | 1 | 8 | 87 |
GO:0016605 | PML body | 7.09e-02 | 1.00e+00 | 3.770 | 1 | 5 | 92 |
GO:0006928 | cellular component movement | 7.09e-02 | 1.00e+00 | 3.770 | 1 | 7 | 92 |
GO:0006414 | translational elongation | 7.16e-02 | 1.00e+00 | 3.755 | 1 | 11 | 93 |
GO:0001649 | osteoblast differentiation | 7.31e-02 | 1.00e+00 | 3.724 | 1 | 6 | 95 |
GO:0006915 | apoptotic process | 7.39e-02 | 1.00e+00 | 2.137 | 2 | 34 | 571 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 7.98e-02 | 1.00e+00 | 3.594 | 1 | 8 | 104 |
GO:0014069 | postsynaptic density | 8.12e-02 | 1.00e+00 | 3.566 | 1 | 1 | 106 |
GO:0005815 | microtubule organizing center | 8.42e-02 | 1.00e+00 | 3.513 | 1 | 4 | 110 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 8.71e-02 | 1.00e+00 | 3.461 | 1 | 10 | 114 |
GO:0019058 | viral life cycle | 8.79e-02 | 1.00e+00 | 3.449 | 1 | 10 | 115 |
GO:0072562 | blood microparticle | 8.86e-02 | 1.00e+00 | 3.436 | 1 | 4 | 116 |
GO:0005635 | nuclear envelope | 8.86e-02 | 1.00e+00 | 3.436 | 1 | 6 | 116 |
GO:0043524 | negative regulation of neuron apoptotic process | 9.08e-02 | 1.00e+00 | 3.399 | 1 | 2 | 119 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 9.66e-02 | 1.00e+00 | 3.305 | 1 | 5 | 127 |
GO:0006413 | translational initiation | 9.95e-02 | 1.00e+00 | 3.261 | 1 | 12 | 131 |
GO:0009615 | response to virus | 1.00e-01 | 1.00e+00 | 3.250 | 1 | 6 | 132 |
GO:0003735 | structural constituent of ribosome | 1.07e-01 | 1.00e+00 | 3.154 | 1 | 8 | 141 |
GO:0007507 | heart development | 1.07e-01 | 1.00e+00 | 3.154 | 1 | 5 | 141 |
GO:0016887 | ATPase activity | 1.09e-01 | 1.00e+00 | 3.124 | 1 | 7 | 144 |
GO:0061024 | membrane organization | 1.10e-01 | 1.00e+00 | 3.104 | 1 | 5 | 146 |
GO:0006457 | protein folding | 1.12e-01 | 1.00e+00 | 3.075 | 1 | 8 | 149 |
GO:0046777 | protein autophosphorylation | 1.19e-01 | 1.00e+00 | 2.990 | 1 | 3 | 158 |
GO:0000398 | mRNA splicing, via spliceosome | 1.24e-01 | 1.00e+00 | 2.928 | 1 | 12 | 165 |
GO:0030424 | axon | 1.29e-01 | 1.00e+00 | 2.868 | 1 | 3 | 172 |
GO:0004672 | protein kinase activity | 1.33e-01 | 1.00e+00 | 2.818 | 1 | 2 | 178 |
GO:0031625 | ubiquitin protein ligase binding | 1.34e-01 | 1.00e+00 | 2.802 | 1 | 13 | 180 |
GO:0043687 | post-translational protein modification | 1.35e-01 | 1.00e+00 | 2.794 | 1 | 4 | 181 |
GO:0003924 | GTPase activity | 1.50e-01 | 1.00e+00 | 2.629 | 1 | 9 | 203 |
GO:0006184 | GTP catabolic process | 1.62e-01 | 1.00e+00 | 2.513 | 1 | 9 | 220 |
GO:0008380 | RNA splicing | 1.70e-01 | 1.00e+00 | 2.436 | 1 | 13 | 232 |
GO:0006412 | translation | 1.72e-01 | 1.00e+00 | 2.417 | 1 | 15 | 235 |
GO:0006281 | DNA repair | 1.91e-01 | 1.00e+00 | 2.250 | 1 | 22 | 264 |
GO:0000166 | nucleotide binding | 1.96e-01 | 1.00e+00 | 2.207 | 1 | 6 | 272 |
GO:0005975 | carbohydrate metabolic process | 1.98e-01 | 1.00e+00 | 2.196 | 1 | 5 | 274 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.98e-01 | 1.00e+00 | 2.191 | 1 | 6 | 275 |
GO:0007283 | spermatogenesis | 1.99e-01 | 1.00e+00 | 2.185 | 1 | 6 | 276 |
GO:0019899 | enzyme binding | 2.07e-01 | 1.00e+00 | 2.124 | 1 | 11 | 288 |
GO:0005856 | cytoskeleton | 2.21e-01 | 1.00e+00 | 2.013 | 1 | 8 | 311 |
GO:0007411 | axon guidance | 2.31e-01 | 1.00e+00 | 1.941 | 1 | 9 | 327 |
GO:0005525 | GTP binding | 2.32e-01 | 1.00e+00 | 1.936 | 1 | 11 | 328 |
GO:0043231 | intracellular membrane-bounded organelle | 2.35e-01 | 1.00e+00 | 1.919 | 1 | 8 | 332 |
GO:0005813 | centrosome | 2.39e-01 | 1.00e+00 | 1.889 | 1 | 12 | 339 |
GO:0003723 | RNA binding | 2.49e-01 | 1.00e+00 | 1.822 | 1 | 19 | 355 |
GO:0005925 | focal adhesion | 2.58e-01 | 1.00e+00 | 1.763 | 1 | 18 | 370 |
GO:0007155 | cell adhesion | 2.66e-01 | 1.00e+00 | 1.709 | 1 | 8 | 384 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.90e-01 | 1.00e+00 | 1.566 | 1 | 14 | 424 |
GO:0007596 | blood coagulation | 3.13e-01 | 1.00e+00 | 1.436 | 1 | 14 | 464 |
GO:0045893 | positive regulation of transcription, DNA-templated | 3.26e-01 | 1.00e+00 | 1.366 | 1 | 17 | 487 |
GO:0048471 | perinuclear region of cytoplasm | 3.45e-01 | 1.00e+00 | 1.263 | 1 | 12 | 523 |
GO:0005783 | endoplasmic reticulum | 3.91e-01 | 1.00e+00 | 1.041 | 1 | 9 | 610 |
GO:0005730 | nucleolus | 3.94e-01 | 1.00e+00 | 0.576 | 2 | 70 | 1684 |
GO:0045087 | innate immune response | 3.94e-01 | 1.00e+00 | 1.027 | 1 | 20 | 616 |
GO:0005794 | Golgi apparatus | 4.11e-01 | 1.00e+00 | 0.950 | 1 | 14 | 650 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 4.85e-01 | 1.00e+00 | 0.630 | 1 | 19 | 811 |
GO:0005615 | extracellular space | 5.64e-01 | 1.00e+00 | 0.314 | 1 | 17 | 1010 |
GO:0008270 | zinc ion binding | 5.85e-01 | 1.00e+00 | 0.235 | 1 | 12 | 1067 |
GO:0003677 | DNA binding | 6.75e-01 | 1.00e+00 | -0.106 | 1 | 26 | 1351 |
GO:0006351 | transcription, DNA-templated | 7.35e-01 | 1.00e+00 | -0.336 | 1 | 25 | 1585 |
GO:0005886 | plasma membrane | 9.16e-01 | 1.00e+00 | -1.175 | 1 | 38 | 2834 |